NCT00179335View on ClinicalTrials.gov

Comparative Pharmacokinetics (PK) Study of Efavirenz or Lopinavir/Ritonavir Between Older and Younger HIV-Infected Adults

CompletedOBSERVATIONAL
Enrollment

45

Participants

Timeline

Start Date

August 31, 2003

Primary Completion Date

January 31, 2006

Study Completion Date

September 30, 2006

Conditions
HIV Infections
Interventions
PROCEDURE

Blood drawing to determine drug levels

Trial Locations (1)

10461

Jacobi Medical Center ACS Clinic, The Bronx

Sponsors

Collaborators (1)

Abbott
All Listed Sponsors
collaborator

Abbott

INDUSTRY

collaborator

University of Alabama at Birmingham

OTHER

lead

Albert Einstein College of Medicine

OTHER

NCT00179335 - Comparative Pharmacokinetics (PK) Study of Efavirenz or Lopinavir/Ritonavir Between Older and Younger HIV-Infected Adults | Biotech Hunter | Biotech Hunter